Findings from a randomized controlled trial of Metacognitive Reflection and Insight Therapy for people with schizophrenia: Effects on metacognition and symptoms
Overview
This randomized controlled trial evaluates Metacognitive Reflection and Insight Therapy (MERIT) for 54 adults with schizophrenia, focusing on its impact on metacognition and psychiatric symptoms. The study compares an immediate intervention group against a waiting condition to assess changes in reflective abilities and symptom severity over time. Results indicate significant improvements in metacognition and reductions in positive, negative, and cognitive symptoms among those receiving the therapy.
- ID
15722277a0214775- Source org
- OpenAlex
- Author
- Ilanit Hasson‐Ohayon (Bar-Ilan University), Libby Igra (University of Copenhagen), Adi Lavi‐Rotenberg (Bar-Ilan University), Gil Goldzweig (Academic College of Tel Aviv-Yafo), Paul H. Lysaker (Richard L. Roudebush VA Medical Center)
- Published
- 2023-07-31
- OA status
- hybrid
- DOI
- 10.1111/papt.12485
- PMID
- Not recorded
- PMCID
- Not recorded
- Citations
- 20
Tags
Verification
- identityok via crossref · score 1 · checked_at unknown
- legitimacykeep via unknown · score 1 · checked_at unknown
- linkblocked via http-check · 2026-07-28T05:51:39.503185+00:00
Cite this entry
BibTeX
@article{allodium:15722277a0214775,
title = {Findings from a randomized controlled trial of Metacognitive Reflection and Insight Therapy for people with schizophrenia: Effects on metacognition and symptoms},
author = {Ilanit Hasson‐Ohayon and Libby Igra and Adi Lavi‐Rotenberg and Gil Goldzweig and Paul H. Lysaker},
year = {2023},
journal = {OpenAlex},
doi = {10.1111/papt.12485},
url = {https://doi.org/10.1111/papt.12485}
}RIS
TY - JOUR TI - Findings from a randomized controlled trial of Metacognitive Reflection and Insight Therapy for people with schizophrenia: Effects on metacognition and symptoms AU - Hasson‐Ohayon, Ilanit AU - Igra, Libby AU - Lavi‐Rotenberg, Adi AU - Goldzweig, Gil AU - Lysaker, Paul H. PY - 2023 PB - OpenAlex DO - 10.1111/papt.12485 UR - https://doi.org/10.1111/papt.12485 ER -
APA
Hasson‐Ohayon, I., Igra, L., Lavi‐Rotenberg, A., Goldzweig, G., & Lysaker, P. H. (2023). Findings from a randomized controlled trial of Metacognitive Reflection and Insight Therapy for people with schizophrenia: Effects on metacognition and symptoms. OpenAlex. https://doi.org/10.1111/papt.12485
Related entries
- Metacognition and recovery in schizophrenia: From research to the development of metacognitive reflection and insight therapy
- Metacognitive reflection and insight therapy (MERIT) for patients with schizophrenia
- A qualitative evaluation of the effects of Metacognitive Reflection and Insight Therapy: ‘Living more consciously’
- Metacognitive Reflection and Insight Therapy for Schizophrenia: Case Study of a Patient With a Co-Occurring Substance Use Disorder
- Metacognitive Reflection and Insight Therapy (MERIT) Among People With Schizophrenia: Lessons From Two Case Studies
- Metacognitive Reflection and Insight Therapy (MERIT) with a Patient with Persistent Negative Symptoms
- Practical Implications of Metacognitively Oriented Psychotherapy in Psychosis
- Metacognitive Reflection and Insight Therapy (MERIT) With a Patient With Severe Symptoms of Disorganization
- Metacognitive Reflection and Insight Therapy (MERIT) for Persons With a Schizophrenia Spectrum Disorder and Interpersonal Trauma
- <p>Metacognitive Reflection and Insight Therapy: A Recovery-Oriented Treatment Approach for Psychosis</p>